NIT
JAZZ icon

NumerixS Investment Technologies’s Jazz Pharmaceuticals JAZZ Stock Holding History

NumerixS Investment Technologies’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-189
Closed -$19K – 1181
2020
Q1 		$19K Sell
189
-1,211
-87% -$157K 0.01% 805
2019
Q4 		$209K Sell
1,400
-2,600
-65% -$354K 0.04% 479
2019
Q3 		$513K Buy
+4,000
New +$536K 0.13% 160
2019
Q2 		– Sell
-9,200
Closed -$1.29M – 1210
2019
Q1 		$1.29M Buy
9,200
+7,600
+475% +$991K 0.17% 139
2018
Q4 		$195K Buy
1,600
+300
+23% +$44.5K 0.06% 352
2018
Q3 		$216K Sell
1,300
-3,100
-70% -$533K 0.04% 558
2018
Q2 		$765K Sell
4,400
-1,100
-20% -$180K 0.17% 160
2018
Q1 		$812K Buy
5,500
+3,299
+150% +$484K 0.2% 111
2017
Q4 		$296K Buy
+2,201
New +$305K 0.07% 342
2017
Q1 		– Sell
-700
Closed -$76K – 1260
2016
Q4 		$76K Sell
700
-1,700
-71% -$189K 0.01% 906
2016
Q3 		$292K Sell
2,400
-17,399
-88% -$2.35M 0.04% 561
2016
Q2 		$2.8M Buy
19,799
+2,440
+14% +$360K 0.39% 35
2016
Q1 		$2.27M Buy
17,359
+3,600
+26% +$448K 0.26% 81
2015
Q4 		$1.93M Sell
13,759
-31,525
-70% -$4.37M 0.24% 85
2015
Q3 		$6.01M Buy
45,284
+40,284
+806% +$6.94M 0.69% 27
2015
Q2 		$880K Buy
+5,000
New +$898K 0.12% 224
2015
Q1 		– Sell
-2,302
Closed -$377K – 631
2014
Q4 		$377K Buy
+2,302
New +$382K 0.13% 240

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

NumerixS Investment Technologies's JAZZ Position: Q2 2020 in Review

NumerixS Investment Technologies sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2020, closing a stake of 189 shares — an estimated $19K sold.

NumerixS Investment Technologies first reported a position in JAZZ in Q4 2014 and held it in 17 quarters. The position peaked at $6.01M in Q3 2015. 384 funds tracked by Wall St. Rank hold JAZZ as of Q2 2020.

  • NumerixS Investment Technologies reported no remaining Jazz Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 189 Jazz Pharmaceuticals shares in Q2 2020, an estimated $19K.
  • NumerixS Investment Technologies first reported a position in Jazz Pharmaceuticals in Q4 2014 and held it in 17 quarters.
  • NumerixS Investment Technologies's Jazz Pharmaceuticals position peaked at $6.01M in Q3 2015.
  • 384 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2020.

Based on NumerixS Investment Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.